Stephen C Farrell Staar Surgical CO (STAA) insider trading activity

Stephen C Farrell is President & CEO of STAAR SURGICAL CO. Currently has a direct ownership of 35,156 shares of STAA, which is worth approximately $617,690. The most recent transaction as insider was on Mar 05, 2025, when has been sold 20,000 shares (Common Stock) at a price of $6.95 per share, resulting in proceeds of $139,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.2K

131.96% 3M change

172.27% 12M change

Total Value Held $617,690

STEPHEN C FARRELL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2025	BUY Exercise of conversion of derivative security	$139,000 $6.95 p/Share	20,000 Added 36.26%	35,156 Common Stock
Jun 20 2024	BUY Grant, award, or other acquisition	-	2,244 Added 12.9%	15,156 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$28,744 $31.21 p/Share	921 Added 6.66%	12,912 Common Stock
Nov 06 2023	BUY Grant, award, or other acquisition	$105,450 $35.15 p/Share	3,000 Added 20.01%	11,991 Common Stock
Sep 29 2023	BUY Grant, award, or other acquisition	$28,728 $40.18 p/Share	715 Added 7.37%	8,991 Common Stock
Jun 15 2023	BUY Exercise of conversion of derivative security	-	1,709 Added 17.12%	8,276 Common Stock
Jun 16 2022	BUY Exercise of conversion of derivative security	-	355 Added 5.13%	6,567 Common Stock
Jun 24 2021	BUY Exercise of conversion of derivative security	-	404 Added 6.11%	6,212 Common Stock
May 28 2021	SELL Sale (or disposition) back to the issuer	$750,000 $150.0 p/Share	5,000 Reduced 46.26%	5,808 Common Stock
May 28 2021	BUY Exercise of conversion of derivative security	$27,700 $5.54 p/Share	5,000 Added 31.63%	10,808 Common Stock
May 26 2021	SELL Sale (or disposition) back to the issuer	$675,000 $135.0 p/Share	5,000 Reduced 46.26%	5,808 Common Stock
May 26 2021	BUY Exercise of conversion of derivative security	$35,700 $7.14 p/Share	5,000 Added 31.63%	10,808 Common Stock
May 19 2021	SELL Sale (or disposition) back to the issuer	$600,000 $120.0 p/Share	5,000 Reduced 46.26%	5,808 Common Stock
May 19 2021	BUY Exercise of conversion of derivative security	$27,700 $5.54 p/Share	5,000 Added 31.63%	10,808 Common Stock
May 17 2021	SELL Sale (or disposition) back to the issuer	$606,699 $113.87 p/Share	5,328 Reduced 47.84%	5,808 Common Stock
May 17 2021	BUY Exercise of conversion of derivative security	$38,042 $7.14 p/Share	5,328 Added 32.36%	11,136 Common Stock

Also insider at

CNVY

Convey Health Solutions Holdings, Inc. Healthcare

CHIEF EXECUTIVE OFFICER

SCF